COVID-19 prevalence and mortality in longer-term care facilities.

Aged COVID-19 Humans Long-Term Care Pandemics Prevalence SARS-CoV-2
SARS-CoV-2 care facilities infection fatality rate nursing homes seroprevalence

Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 09 02 2022
accepted: 04 03 2022
pubmed: 11 4 2022
medline: 19 5 2022
entrez: 10 4 2022
Statut: ppublish

Résumé

This essay considers the factors that have contributed to very high COVID-19 mortality in longer-term care facilities (LTCFs). We compare the demographic characteristics of LTCF residents with those of community-dwelling older adults, and then we review the evidence regarding prevalence and infection fatality rates (IFRs), including links to frailty and some comorbidities. Finally, we discuss policy measures that could foster the physical and mental health and well-being of LTCF residents in the present context and in potential future pandemics.

Identifiants

DOI: 10.1007/s10654-022-00861-w PMID: 35397704 PMC: PMC8994824
pubmed: 35397704
doi: 10.1007/s10654-022-00861-w
pii: 10.1007/s10654-022-00861-w
pmc: PMC8994824
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

227-234

Informations de copyright

© 2022. The Author(s).

Références

Geroscience. 2020 Aug;42(4):1063-1074
pubmed: 32677025
Int J Environ Res Public Health. 2021 Aug 22;18(16):
pubmed: 34444600
JAMA Intern Med. 2021 Apr 1;181(4):439-448
pubmed: 33394006
N Engl J Med. 2020 Oct 29;383(18):1724-1734
pubmed: 32871063
EClinicalMedicine. 2021 Mar;33:100771
pubmed: 33681730
BMC Geriatr. 2021 Mar 17;21(1):186
pubmed: 33731018
Int J Legal Med. 2020 Jul;134(4):1275-1284
pubmed: 32500199
J Clin Med. 2020 Aug 27;9(9):
pubmed: 32867328
Euro Surveill. 2022 Mar;27(9):
pubmed: 35241216
Environ Res. 2021 Apr;195:110856
pubmed: 33581086
Sci Rep. 2021 Feb 19;11(1):4263
pubmed: 33608563
J Am Geriatr Soc. 2021 Oct;69(10):2766-2777
pubmed: 34549415
J Am Geriatr Soc. 2012 Aug;60(8):1487-92
pubmed: 22881367
Eur Geriatr Med. 2020 Dec;11(6):1089-1094
pubmed: 32734464
Int J Geriatr Psychiatry. 2013 Nov;28(11):1109-24
pubmed: 23526458
Sci Rep. 2021 Apr 12;11(1):7966
pubmed: 33846416
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1296-1299
pubmed: 32941413
Age Ageing. 2021 Jun 28;50(4):1019-1028
pubmed: 33710281
Front Med (Lausanne). 2021 May 24;8:678347
pubmed: 34109200
Sci Rep. 2021 Feb 18;11(1):3504
pubmed: 33603008
Lancet Healthy Longev. 2021 Mar;2(3):e113-e114
pubmed: 33655234
J Am Med Dir Assoc. 2020 Oct;21(10):1378-1383.e1
pubmed: 32981664
J Am Med Dir Assoc. 2021 Feb;22(2):245-252.e2
pubmed: 33417840
Eur J Epidemiol. 2022 Mar;37(3):235-249
pubmed: 35306604
J Am Geriatr Soc. 2020 Oct;68(10):2167-2173
pubmed: 32674223
BMC Infect Dis. 2021 Feb 22;21(1):198
pubmed: 33618660
Age Ageing. 2021 Jun 28;50(4):1038-1047
pubmed: 33945607
JAMA Netw Open. 2020 Jul 1;3(7):e2015957
pubmed: 32697325
J Am Med Dir Assoc. 2021 Jun;22(6):1149-1150
pubmed: 33989538
Int J Epidemiol. 2022 Feb 18;51(1):63-74
pubmed: 34564730
J Am Med Dir Assoc. 2021 Aug;22(8):1574-1580.e8
pubmed: 34174196
Alzheimer Dis Assoc Disord. 2010 Jan-Mar;24(1):90-5
pubmed: 19568155
J Am Geriatr Soc. 2021 Dec;69(12):3377-3388
pubmed: 34409590
Gates Open Res. 2021 Aug 27;5:143
pubmed: 35441127
Ageing Res Rev. 2021 Dec;72:101498
pubmed: 34700009
Lancet Healthy Longev. 2021 Mar;2(3):e129-e142
pubmed: 33655236
Geroscience. 2021 Oct;43(5):2265-2287
pubmed: 34510338
Age Ageing. 2020 Aug 24;49(5):748-757
pubmed: 32396600
J Am Geriatr Soc. 2020 Nov;68(11):2462-2466
pubmed: 32770832
J Am Med Dir Assoc. 2021 Jun;22(6):1128-1132
pubmed: 33932351
JAMA Intern Med. 2021 Apr 1;181(4):448-449
pubmed: 33394009
Biogerontology. 2022 Feb;23(1):53-64
pubmed: 34923608
Eur J Epidemiol. 2020 Dec;35(12):1123-1138
pubmed: 33289900
J Am Geriatr Soc. 2021 May;69(5):1128-1139
pubmed: 33619733
CMAJ. 2021 May 10;193(19):E681-E688
pubmed: 33972221
Science. 2020 Oct 9;370(6513):159-163
pubmed: 33033200
Lancet. 2020 Oct 24;396(10259):1335-1344
pubmed: 32987007
Lancet Healthy Longev. 2020 Oct;1(1):e21-e31
pubmed: 34173614
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Int J Epidemiol. 2022 Jan 6;50(6):1804-1813
pubmed: 34999883
J Public Health (Oxf). 2022 Mar 7;44(1):e20-e25
pubmed: 33839789
Eur J Epidemiol. 2021 Jul;36(7):727-734
pubmed: 33884542
BMJ. 2021 Nov 3;375:e066768
pubmed: 34732390
Transl Med UniSa. 2014 Apr 24;9:1-6
pubmed: 24809027
Clin Infect Dis. 2020 Dec 15;71(12):3174-3181
pubmed: 32609825
Lancet Healthy Longev. 2021 Jun;2(6):e362-e370
pubmed: 34104901
J Am Med Dir Assoc. 2020 Nov;21(11):1572-1574.e3
pubmed: 33138940
J Intern Med. 2021 Sep;290(3):655-665
pubmed: 33872433
Public Health. 2017 Nov;152:157-171
pubmed: 28915435
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):965-970
pubmed: 32701941
PLoS One. 2022 Jan 20;17(1):e0262807
pubmed: 35051237
PLoS One. 2018 Jan 4;13(1):e0190033
pubmed: 29300743
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Transfusion. 2021 Mar;61(3):862-872
pubmed: 33527398
Front Public Health. 2021 Feb 04;8:589371
pubmed: 33614564
BMC Geriatr. 2021 Jun 7;21(1):349
pubmed: 34098883

Auteurs

Andrew T Levin (AT)

Dartmouth College, Hanover, USA. andrew.t.levin@dartmouth.edu.
National Bureau for Economic Research, Cambridge, USA. andrew.t.levin@dartmouth.edu.
Center for Economic Policy Research, London, United Kingdom. andrew.t.levin@dartmouth.edu.
ORCID: 0000-0002-1136-6900

Juulia Jylhävä (J)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Faculty of Social Sciences, Unit of Health Sciences and Gerontology Research Center, University of Tampere, Tampere, Finland.

Dorota Religa (D)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Laura Shallcross (L)

University College, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › COVID-19 prevalence and mortality in...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › COVID-19 prevalence and mortality in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › COVID-19 prevalence and mortality in...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Soins aux patients › Soins de longue durée › COVID-19 prevalence and mortality in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › COVID-19 prevalence and mortality in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › COVID-19 prevalence and mortality in...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › COVID-19 prevalence and mortality in...